| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |